<DOC>
	<DOC>NCT01781533</DOC>
	<brief_summary>To investigate the performance of a software-algorithm based insulin therapy to control blood glucose in Type 1 diabetic patients.</brief_summary>
	<brief_title>Study to Test Software Algorithm for Insulin Therapy and New Glucose Sensor</brief_title>
	<detailed_description />
	<criteria>Male or female aged 18 to 75 years (both inclusive) Informed consent obtained after being advised of the nature of the study The subject has Type 1 diabetes (as defined by WHO) for at least 24 months The subject's HbA1c &lt;= 10% Body Mass Index (BMI) &lt;= 35 kg/m2 The subject is treated with continuous subcutaneous insulin infusion for at least 3 month Subject is actively enrolled in another clinical trial or took part in a study within 30 days Experienced recurrent severe hypoglycaemic unawareness Total daily insulin dose &gt;= 1.4 IU/kg Subject is using a medication that significantly impacts glucose metabolism (oral or topical steroids) except if stable for at least the last three months and expected to remain stable for the study duration Allergy against insulin Lispro A history of drug or alcohol dependence Any other significant concomitant disease such as endocrine, cardiac, neurological, malignant, other pancreatic disease or uncontrolled hypertension as judged by the investigator Uncontrolled hypertension with resting blood pressure over 140/90 mmHg Patient is pregnant, or breast feeding during the period of the study Patient donated blood in the last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>